Trial intelligence / Profile preview

RhizomK for Testosterone and Performance in Healthy Males

NCT07143474Not yet recruiting

Sponsor
AIIMS New Delhi
Start
Oct 2025
Primary completion
Oct 2026
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Serum testosterone levels at 4 weeks. Planned start Oct 2025; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07143474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07143474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call